MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
933-939
Author(s):
Morteza Ghandadi and Amirhossein Sahebkar
Can Probiotics Cure Inflammatory Bowel Diseases?
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
904-917
Author(s):
Siva Kumar Korada, Nagendra sastry Yarla, Anupam Bishayee, Gjumrakch Aliev, Aruna Lakshmi K., Arunasree M.K., Dhananjaya B.L. and Vijendra Mishra
Cadherins: The Superfamily Critically Involved in Breast Cancer
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
616-638
Author(s):
Maeirah Afzal Ashaie and Ezharul Hoque Chowdhury
Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
518-526
Author(s):
Morteza Ghandadi and Amirhossein Sahebkar
New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Journal:
Current Drug Targets
Volume:
17
Page:
353-374
Author(s):
Paola Savoia, Ottavio Cremona and Paolo Fava
Prognostic Factors after R0 Resection of Colorectal Cancer Liver Metastases: A Systematic Review and Pooled-Analysis
Journal:
Reviews on Recent Clinical Trials
Volume:
11
Page:
56-62
Author(s):
Fausto Petrelli, Andrea Coinu, Alberto Zaniboni, Filippo Pietrantonio and Sandro Barni
Anti-VEGF Therapy for Retinal Vein Occlusions
Journal:
Current Drug Targets
Volume:
17
Page:
328-336
Author(s):
Claudio Campa, Giuseppe Alivernini, Elena Bolletta, Maurizio Battaglia Parodi and Paolo Perri
Compartmentalized Platforms for Neuro-Pharmacological Research
Journal:
Current Neuropharmacology
Volume:
14
Page:
72-86
Author(s):
Amol D. Jadhav, Li Wei and Peng Shi
Using NMR to Develop New Allosteric and Allo-Network Drugs
Journal:
Current Drug Discovery Technologies
Volume:
12
Page:
193-204
Author(s):
Robert E. Smith, Kevin Tran, Kristy M. Richards and Rensheng Luo
Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
201-241
Author(s):
Howard S. Roth and Paul J. Hergenrother